HQ LocationKelowna, British Columbia, Canada
ManagementChris Bunka, CEO
About Lexaria Bio Science
Lexaria Bio Science increased its popularity level in 2014 when they developed the DehydraTech technology. Ever since, the company with Chris Bunka as its CEO has broadened and strengthened the technology on a global level. They are now considered global leaders in enhancing the efficiency and speed of drugs that are delivered orally. To be more, Lexaria demonstrated effectiveness in terms of delivery through human skin with topicals.